Dowden Nathan J — SEC insider filings

SEC reporting owner CIK 1873392. 29 insider filings on record with FilingPulse; latest filed 2026-09-03.

Transaction summary — filings shown

Covers all 29 filings on record, filed 2021-11-01 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Entrada Therapeutics, Inc. (TRDA)President & COO29—31 legs · 119,090 sh · $1,900,23137

Insider filings — Dowden Nathan J

FiledFormIssuerReported transactionsSource
2026-09-034Entrada Therapeutics, Inc. (TRDA)Tax withholding (F): 2,528 @ $7.14EDGAR
2026-05-044Entrada Therapeutics, Inc. (TRDA)Option exercise (M): 15,000 @ $1.74 · Sale (S): 15,000 @ $15.33 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2026-03-114Entrada Therapeutics, Inc. (TRDA)Sale (S): 3,116 @ $13.02 · Sale (S): 11,894 @ $13.05EDGAR
2026-03-034Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 55,800 @ $0 · Tax withholding (F): 7,223 @ $11.66 · Tax withholding (F): 14,038 @ $11.76 · Grant/award (A): 83,200 (derivative) @ $0EDGAR
2025-09-044Entrada Therapeutics, Inc. (TRDA)Tax withholding (F): 1,746 @ $5.43EDGAR
2025-03-044Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 60,800 @ $0 · Tax withholding (F): 5,144 @ $11.68 · Grant/award (A): 90,800 (derivative) @ $0EDGAR
2024-09-304Entrada Therapeutics, Inc. (TRDA)Sale (S): 847 @ $16EDGAR
2024-09-104Entrada Therapeutics, Inc. (TRDA)Sale (S): 399 @ $15.19 · Sale (S): 1,904 @ $15.07EDGAR
2024-09-054Entrada Therapeutics, Inc. (TRDA)Tax withholding (F): 483 @ $15.76 · Tax withholding (F): 156 @ $16.93 · Tax withholding (F): 15 @ $17.70 · Tax withholding (F): 983 @ $15.42 · Tax withholding (F): 171 @ $15.13EDGAR
2024-08-204Entrada Therapeutics, Inc. (TRDA)Option exercise (M): 20,000 @ $1.74 · Sale (S): 26,595 @ $16.26 · Sale (S): 502 @ $16.70 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2024-03-084Entrada Therapeutics, Inc. (TRDA)Sale (S): 1,826 @ $12.32EDGAR
2024-03-054Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 33,100 @ $0 · Grant/award (A): 60,000 @ $0 · Tax withholding (F): 343 @ $12.42 · Tax withholding (F): 409 @ $13.37 · Tax withholding (F): 1,486 @ $12.28 · Grant/award (A): 50,100 (derivative) @ $0EDGAR
2023-09-064Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 14,200 @ $0 · Tax withholding (F): 436 @ $14.46 · Sale (S): 913 @ $13.43 · Sale (S): 59 @ $14.01 · Grant/award (A): 21,500 (derivative) @ $0EDGAR
2023-07-124Entrada Therapeutics, Inc. (TRDA)Sale (S): 3,200 @ $18.00 · Sale (S): 3,897 @ $18.05EDGAR
2023-06-224Entrada Therapeutics, Inc. (TRDA)Sale (S): 8,885 @ $14.94 · Sale (S): 7,097 @ $16.02EDGAR
2023-04-194/AEntrada Therapeutics, Inc. (TRDA)Grant/award (A): 14,200 @ $0 · Grant/award (A): 21,500 (derivative) @ $0EDGAR
2023-03-034Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 28,400 @ $0 · Tax withholding (F): 1,028 @ $11.60 · Grant/award (A): 43,000 (derivative) @ $0EDGAR
2022-11-024Entrada Therapeutics, Inc. (TRDA)Sale (S): 2,100 @ $24.05EDGAR
2022-10-274Entrada Therapeutics, Inc. (TRDA)Sale (S): 3,034 @ $20.10 · Sale (S): 5,414 @ $20.97 · Sale (S): 900 @ $21.85EDGAR
2022-10-244Entrada Therapeutics, Inc. (TRDA)Sale (S): 905 @ $18.07 · Sale (S): 2,771 @ $18.29 · Sale (S): 1,102 @ $18.88 · Sale (S): 1,302 @ $19.66EDGAR
2022-09-284Entrada Therapeutics, Inc. (TRDA)Sale (S): 1,329 @ $15.32 · Sale (S): 215 @ $16.25EDGAR
2022-09-234Entrada Therapeutics, Inc. (TRDA)Sale (S): 3,275 @ $15.13 · Sale (S): 1,018 @ $15.07EDGAR
2022-09-194Entrada Therapeutics, Inc. (TRDA)Sale (S): 100 @ $15.01EDGAR
2022-09-124Entrada Therapeutics, Inc. (TRDA)Sale (S): 912 @ $15.15 · Sale (S): 865 @ $15.06EDGAR
2022-09-064Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 5,632 @ $0EDGAR
2022-07-064Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 33,788 (derivative) @ $0EDGAR
2022-06-294Entrada Therapeutics, Inc. (TRDA)Sale (S): 7,714 @ $13EDGAR
2022-03-034Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 11,263 @ $0 · Grant/award (A): 67,575 (derivative) @ $0EDGAR
2021-11-014Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 95,148 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-10-27 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1873392 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs